Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies has announced a conference call for analysts and investors to discuss its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The call is scheduled for Wednesday, August 6, 2025, at 4:00 PM IST, with dial-in numbers provided for participants in India, USA, UK, Singapore, and Hong Kong. Top management will be present, including Chairperson Vasant Rathi, Whole-time Director Mukund Kabra, and CFO Beni Prasad Rauka. The disclosure is filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30).
This is a routine regulatory intimation and does not directly impact the stock price. However, the upcoming Q1 results and management commentary during the call could influence investor sentiment and near-term price movement.